Evidence and label comparisons · WSNC nutrition education
Astragalus Supplements: Root Extracts and Complete Immune Formulas
Astragalus Complex combines astragalus with echinacea and eleuthero. Its root extract amount describes only one part of the formula; compare all three herbs and the labeled serving before using a broad immune-support description.
Compare the exact preparation and labeled serving
The manufacturer lists astragalus root extract separately from echinacea and eleuthero extracts. Original-root equivalents differ from extract weights. The complete tablet is not astragalus alone.
The amounts below reproduce the inspected manufacturer online panel. They describe labeled servings, not an individualized regimen. Confirm your selected package and review the full ingredient list and dietary attributes on the product page.
| Product | Declared serving facts | Important distinction |
|---|---|---|
| Astragalus ComplexView product → | Declared serving factsEach Serving Size (1 Tablet) contains: Astragalus root 4:1 extract 212.5 mg, (from Astragalus membranaceus root 850 mg), Echinacea root 5:1 extract 130 mg (from Echinacea purpurea root 650 mg), Eleuthero root 10:1 extract 75 mg (from Eleutherococcus senticosus root 750 mg, Containing syringaresinol diglucosides 600 mcg). | Important distinctionRead the complete Astragalus Complex ingredient list and current package. The serving facts describe this formula; a shared ingredient does not make it equivalent to another product. |
References: WSNC Astragalus Complex recorded label details ↗ · Astragalus: Usefulness and Safety | NCCIH ↗
What the ingredient evidence can establish
NCCIH concludes that reliable evidence is insufficient to establish astragalus as useful for a health condition. Some reviews report changes in selected immune or metabolic measures, but small studies, bias and inconsistent methods limit confidence.
Biomarker changes do not demonstrate prevention of infection or treatment of autoimmune or kidney disease. Findings from an adjunct to prescribed treatment cannot justify replacing that treatment or assigning the same effects to another oral combination.
References: Astragalus: Usefulness and Safety | NCCIH ↗
Review suitability, medicines and the whole formula
People with autoimmune disease should avoid astragalus according to NCCIH, and immunosuppressive medicines require particular review. Pregnancy and nursing safety is not established. Discuss the echinacea and eleuthero components too.
Establish the clinical and medicine context before considering an immune-focused botanical. A practitioner review should address the whole combination rather than one ingredient headline.
References: WSNC Astragalus Complex recorded label details ↗ · Astragalus: Usefulness and Safety | NCCIH ↗
Prepare a focused practitioner conversation
Bring the selected label, your reason for considering astragalus, and a list of medicines and other supplements. Compare the intended outcome with the specific preparation studied, and agree how suitability and any benefit will be assessed.
Manufacturer suggested-use text checked for these products: Astragalus Complex: 1 tablet 2 - 4 times daily, or as directed.
These are separate product instructions, not one combined supplement schedule. Keep the current package directions with your practitioner plan; ingredient research does not override manufacturer labeling.
References: WSNC Astragalus Complex recorded label details ↗ · Astragalus: Usefulness and Safety | NCCIH ↗
Common questions
How should I compare astragalus supplement labels?
The manufacturer lists astragalus root extract separately from echinacea and eleuthero extracts. Original-root equivalents differ from extract weights. The complete tablet is not astragalus alone.
Does ingredient research prove the complete formula works?
Biomarker changes do not demonstrate prevention of infection or treatment of autoimmune or kidney disease. Findings from an adjunct to prescribed treatment cannot justify replacing that treatment or assigning the same effects to another oral combination.
What should I discuss before considering astragalus?
People with autoimmune disease should avoid astragalus according to NCCIH, and immunosuppressive medicines require particular review. Pregnancy and nursing safety is not established. Discuss the echinacea and eleuthero components too.
Evidence and product label sources
WSNC label links below present recorded Standard Process product information on our site. Noncommercial references explain ingredients, evidence limits and safety; they do not verify every formula amount or establish a treatment outcome for a finished product or protocol. The referenced organizations do not endorse this store.
Manufacturer nutrition-panel amounts shown here were checked October 14, 2026. Confirm the current packaging, directions and dietary information before use. Your healthcare practitioner can help assess individual suitability.
How we research products → · Prepare a practitioner conversation →